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The ability to reprogram differentiated cells into a
pluripotent state has revealed that the differentiated
state is plastic and reversible. It is evident, therefore,
that mechanisms must be in place to maintain cells
in a differentiated state. Transcription factors that
specify neuronal characteristics have beenwell stud-
ied, but less is known about the mechanisms that
prevent neurons from dedifferentiating to a multipo-
tent, stem cell-like state. Here, we identify Lola as
a transcription factor that is required tomaintain neu-
rons in a differentiated state. We show that Lola
represses neural stem cell genes and cell-cycle
genes in postmitotic neurons. In lola mutants, neu-
rons dedifferentiate, turn on neural stem cell genes,
and begin to divide, forming tumors. Thus, neurons
rather than stem cells or intermediate progenitors
are the tumor-initiating cells in lola mutants.
INTRODUCTION
Waddington’s ‘‘epigenetic landscape’’ model suggests that the
process of cellular differentiation is essentially irreversible (Wad-
dington, 1957). However, it is now clear that differentiated cells
can be reprogrammed into a pluripotent state (Gurdon, 1962; Ta-
kahashi and Yamanaka, 2006) or into an alternative differentiated
state (Vierbuchenetal., 2010).Therefore, thedifferentiatedstateof
cells is not set in stone; cells can dedifferentiate or transdifferenti-
ate.However, themoredifferentiatedacell is, themoredifficult it is
to reprogram (for review, see Pasque et al., 2011), suggesting that
there are active mechanisms in place to maintain cells in a differ-
entiated state. Although there are now many studies defining the
transcription factors that enable reprogramming, less is known
about the mechanisms that act to prevent cells from dedifferenti-
ating. Identification of these mechanisms will be key for fully un-
derstanding reprogramming and for developing safe methods
for dedifferentiating cells in vivo for therapeutic purposes without
inducing cancer (van Es et al., 2012; Schwitalla et al., 2013).
The Drosophila CNS is an attractive model for studying differ-
entiation of neural stem cells and their progeny as well as inves-Develotigating howmisregulation of self-renewal and differentiation can
lead to tumorigenesis (Wodarz and Gonzalez, 2006; Caussinus
and Hirth, 2007; Doe, 2008; Egger et al., 2008; Neumu¨ller and
Knoblich, 2009). The majority of neural stem cells in the
Drosophila brain and ventral nerve cord (type I neuroblasts) un-
dergo multiple asymmetric divisions whereby they self-renew
while producing daughter cells (GMCs or ganglion mother cells)
that divide only once to give two postmitotic neurons or glial
cells. At each division, cell-fate determinants are segregated
from the neural stem cell to the GMC. These include Prospero
(Doe et al., 1991; Vaessin et al., 1991; Matsuzaki et al., 1992),
Brat (Bello et al., 2006; Betschinger et al., 2006; Lee et al.,
2006b), and Numb (Rhyu et al., 1994), all of which act as tumor
suppressors in the nervous system (Bello et al., 2006; Bet-
schinger et al., 2006; Choksi et al., 2006; Lee et al., 2006a,
2006b; Wang et al., 2006; Bowman et al., 2008). Therefore,
disrupting the neurogenic differentiation pathway can lead to
tumorigenesis.
We showed previously that the atypical homeodomain tran-
scription factor, Prospero, controls the choice between stem
cell self-renewal and differentiation. Prospero represses genes
required for self-renewal, such as neural stem cell genes and
cell-cycle genesbut also is required toactivate genes for neuronal
and glial differentiation (Choksi et al., 2006). In prosperomutants,
GMCs fail to differentiate and revert to a stem cell-like fate. They
continue to divide, express neural stem cell markers, and form
brain tumors (Caussinus and Gonzalez, 2005; Bello et al., 2006;
Betschinger et al., 2006; Choksi et al., 2006; Lee et al., 2006b).
Prospero’s ability both to repress and to activate transcription
suggested that cofactors and/or chromatin remodeling fac-
tors might modulate Prospero’s activity. Prospero is known to
function with a histone deacetylase (HDAC), Rpd3, to control
dendritic targeting in postmitotic neurons (Tea et al., 2010).
The vertebrate homolog of Prospero, Prox1, also interacts with
an HDAC (HDAC3; Shan et al., 2008) as well as with nuclear hor-
mone receptors (Liu et al., 2003; Steffensen et al., 2004; Lee
et al., 2009; Charest-Marcotte et al., 2010). To date, no factors
have been identified that act with Prospero in the switch from
self-renewal to differentiation.
Here, we show that the BTB-Zn finger transcription factor, Lola
(Seeger et al., 1993; Giniger et al., 1994), binds to a large number
of Prospero’s targets, including genes involved both in stem cell
self-renewal and differentiation. Furthermore, like Prospero, Lola
is a tumor suppressor protein. Intriguingly, however, the tumorpmental Cell 28, 685–696, March 31, 2014 ª2014 The Authors 685
Figure 1. Experimental Design for Identi-
fying a Prospero Cofactor
(A) An enriched motif was identified at regions
in the genome bound by Prospero. In the Pros-
pero DamID binding data example, the vertical
bar represents the log2 ration between the
Dam-Prospero signal and the Dam-only signal.
This motif identified was used in a yeast
one-hybrid screen to identify Lola splice isoform
N as a protein that can bind to this DNA
sequence.
(B) Structure of the lola locus. lola generates 25
different splice isoforms that all share a N-terminal
BTB domain but possess one of 17 differing
C-terminal zinc finger domains. The isoform
identified in the yeast one-hybrid screen is high-
lighted (Lola-N).
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Unlike prospero mutants where the first daughter of the neural
stem cell, the GMC, reverts to a stem cell-like state, in lola
mutants newly born neurons dedifferentiate, express stem cell
markers, and proliferate, resulting in brain tumors. We conclude
that, whereas Prospero acts to block self-renewal and initiate
neuronal differentiation, Lola is required to maintain the differen-
tiated state.
RESULTS
Identification of a Prospero Cofactor
Given that Prospero has the ability both to repress and activate
gene expression (Choksi et al., 2006), we reasoned that Pros-
pero is likely to act with proteins that are able to modulate its
activity. To identify the binding sites for potential cofactors, we
analyzed the DNA sequences near Prospero binding sites using
the motif discovery tool MICRA (Southall and Brand, 2009).
MICRA identifies enriched sequences at Prospero binding sites
by extracting and filtering for conserved sequences and calcu-
lating the relative frequency of each 6–10-mer as compared to
the background frequency throughout the genome. The most
enriched 6-mer at Prospero binding sites, to which Prospero
itself does not bind (Cook et al., 2003; Yousef and Matthews,
2005), is the conserved palindromic sequence, CGATCG
(166% enriched). Furthermore, alignment of the most enriched
8-mer generates a position weight matrix (PWM) containing a
core CGATCG sequence (Figure 1A). Members of the GATA
zinc finger transcription factor family (Bryne et al., 2008) bind a
similar sequence (GATDV, GATYDD).
To identify proteins that recognize this motif, we performed a
yeast one-hybrid screen using six copies of the motif as bait
and an embryonic cDNA library as prey. We isolated a specific
isoform of the BTB-zinc finger transcription factor Lola, Lola-N.
The lola locus generates 25 different splice isoforms encoding
20 proteins that share the same N-terminal BTB domain but
different C termini, which can encode one of 17 different zinc fin-
gers, or lack zinc fingers entirely (Goeke et al., 2003; Ohsako
et al., 2003) (Figure 1B). Each of these zinc fingers can potentially
bind a unique DNA sequence.686 Developmental Cell 28, 685–696, March 31, 2014 ª2014 The AuLola-N Is Expressed in Neurons
If Lola acts with Prospero, then we expected that the two pro-
teins would colocalize at some point in development. To deter-
mine the expression pattern of Lola-N, we generated an antibody
against its unique C terminus. Lola-N is expressed in embryos
from stage 11 onward in the differentiating layer of the ventral
nerve cord (VNC) but not in neuroblasts (Figures 2A and 2B).
Lola-N is expressed in all neurons, colocalizing with Elav, but
is undetectable in glial cells (Figures 2C and 2D). Lola-N is also
expressed in neurons of the larval and adult brain (Figure 2G
and Figures S1A–S1G available online).
During neural stem cell self-renewal, Prospero is segregated
from the neuroblast to the GMC. After the GMC has divided,
Prospero is present only transiently in the resultant neurons
(Spana and Doe, 1995). Lola-N expression is induced as Pros-
pero levels decrease, resulting in a brief period of colocalization
(Figure 2E) immediately before, and just after, GMC division, as
determined by phosphohistone H3 (PH3) labeling (arrowheads
in Figure 2F).
Lola-N is expressed in a similar manner in the larval CNS (Fig-
ures 2G and S1A–S1C), except that it overlaps more extensively
with Prospero in the central brain (Figure S1C) where Prospero is
present in at least a subset of postmitotic neurons (Bello et al.,
2006; Tea et al., 2010). Therefore, Lola-N is expressed at an
appropriate time and place to act with Prospero or to modulate
its activity.
Lola-N Represses Neuroblast Genes and Cell-Cycle
Regulators
To assess whether Lola binds to the same genes as Prospero,
we identified the embryonic binding sites of Lola-N throughout
the genome using DamID. Lola-N binds to 1,369 genes (false dis-
covery rate [FDR] < 0.1%) that show a highly significant overlap
(p < 63 1071) with the 836 genes (FDR < 0.1%) bound by Pros-
pero. Two hundred fifty-nine genes are bound by both Prospero
and Lola-N (31% of Prospero’s targets; Figure 3A; Experimental
Procedures). This overlap is specific to Prospero and Lola-N
because only five of the 259 genes (2%) are bound by an
unrelated neural transcription factor (P. Wu and A.H.B., unpub-
lished data).thors
Figure 2. Lola-N Is Expressed in Neurons in the Developing Nervous System
(A and B) Lola-N protein is absent from neuroblasts and present in the differentiating, dorsal region of the VNC (lateral view, stage 14 embryo). Arrowhead
highlights a neuroblast.
(C) Colocalization of Lola-N and the neuronal marker Elav (ventral view, stage 16/17 embryo).
(D) Mutually exclusive expression pattern of Lola-N and the glial marker Repo (ventral view, stage 16/17 embryo).
(E) Lola-N and Prospero briefly overlap in differentiating cells of the VNC (lateral view, stage 14 embryo). Arrowheads identify example cells that express both
Lola-N and Prospero.
(F) Colocalization of low levels of Lola-N with PH3 in the VNC (ventral view, stage 13 embryo). Arrowheads show dividing GMC cells.
(G) Lola-N and Prospero expression in third instar larval brains.
Scale bars represent 20 mM. See also Figure S1.
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riched 6-mer (CGATCG, 253% enriched) is identical to the motif
identified by MICRA analysis of the sequences associated with
Prospero binding peaks, as described above. The core CGATCG
sequence is again integral to a PWM generated from enriched
8-mer (Figure 3B) and provides independent support for the
yeast one-hybrid result.
Lola-N binds both neural stem cell genes and differentiation
genes (Figure 3A). Both Lola-N and Prospero bind key neuro-
blast genes and cell-cycle regulators (Figures 3C, 3E, and 3G),
including brain tumor (brat), deadpan (Hes family related),
dacapo (p27cip/kip), and string (cdc25). They also bind to
many Notch family genes, suggesting that Prospero and Lola-NDevelocoordinately regulate this pathway. Interestingly a second iso-
form of Lola, Lola-T, has been shown to antagonize Notch during
specification of cell fate in the developing Drosophila eye (Zheng
and Carthew, 2008).
To determine how Lola-N regulates its target genes, we ex-
pressed Lola-N ectopically in stripes in the developing embryo.
In cells expressing Lola-N, driven by engrailed-GAL4, transcrip-
tion of the cell-cycle genes CyclinE and string (cdc25) is
repressed (Figures 3F and 2H). Transcription of the genes
encoding the neuroblast transcription factors, deadpan and
asense, is also repressed by Lola-N (Figures 3D, S2A, and
S2B). Therefore, like Prospero, Lola-N is able to directly bind
and repress neural stem cell genes. This is intriguing as Lola-Npmental Cell 28, 685–696, March 31, 2014 ª2014 The Authors 687
(legend on next page)
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Figure 4. Loss of Lola Causes Brain Tumors
(A) prospero mutant clones result in tumors in the
adult brain, in both the central brain and optic lobe
regions.
(B andC) lolaE76mutant clones cause tumors in the
optic lobe regions of the adult brain. The tumors
express the neuroblast marker Deadpan (B) and
contain actively dividing cells (PH3; C).
(D) Expression of Lola-N in lolaE76mutant clones is
sufficient to rescue the tumor phenotype.
(E) actin FLP-out clones that express lola shRNAi
(induced during the second instar larval stage)
result in tumors in the adult brain (five out of nine
brains). Arrowheads highlight dividing cells (PH3).
(F) FLP-out clones that express both lola shRNAi
and Prospero do not cause tumors (11 out of 11
brains). Clones are marked with GFP.
Scale bars represent 100 mM. See also Figure S3.
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ure 2F), at which point Prospero would already have repressed
neural stem cell genes. This suggests that Lola-N’s role might
be in maintaining, rather than in initiating, repression of these
genes.
Loss of lola Causes Tumors
If Lola-N is required to maintain the differentiated state, then the
loss of Lola might result in tumor formation, similar to what has
been observed in prospero mutants. Prospero is required to
block self-renewal and induce differentiation. As a result, the
loss of prospero leads to tumor formation in the developing
Drosophila nervous system. In prospero, mutant GMCs, which
would normally divide terminally to generate postmitotic neu-
rons, instead undergo self-renewing divisions (Choksi et al.,
2006; Lee et al., 2006b).Figure 3. Transcriptional Targets of Lola-N
(A) Comparison of Lola-N and Prospero target genes in the developing embryo.
(B) Identification of the most enriched DNA motif at sites of Lola-N binding. In the Lola-N DamID binding data
between the Dam-Prospero signal and the Dam-only signal.
(C, E, and G) Lola-N and Prospero binding at the dpn, CycE, and string loci. The vertical bars represent the
Dam-only signal. Red bars indicate regions identified as being significantly bound.
(D, F, and H) Lola-N is sufficient to repress the expression of dpn, CycE, and string mRNA in the developing
See also Figure S2.
Developmental Cell 28, 685–69We generated lolaE76 mutant clones
during larval stages using the MARCM
system (Lee and Luo, 2001). lolaE76 is a
protein null mutation, removing all iso-
forms of lola (Goeke et al., 2003). lolaE76
mutant clones proliferate extensively
and give rise to tumors in the adult brain
(Figures 4B and 4C). The mutant cells ex-
press the neuroblast transcription factor,
Deadpan (Figure 4B), and divide actively
as indicated by labeling with phosphohi-
stone H3 (Figure 4C). We observed a
similar phenotype with an independent
lola mutant allele, lola5D2 (Giniger et al.,
1994) (data not shown). lolaE76 mutant
clones form tumors in the optic lobe re-gion of the adult brain (n > 30) but not in the central brain, in
contrast to prosperomutant clones, which can generate tumors
in both regions (Bello et al., 2006; Betschinger et al., 2006; Lee
et al., 2006b) (Figure 4A). Interestingly, Prospero expression per-
sists in the central brain but not in the optic lobe. It is conceivable
that Prospero is able to maintain the repression of neural stem
cell genes in the central brain in the absence of Lola. In support
of this hypothesis, ectopic expression of Prospero is able to
rescue the lola tumor phenotype (Figures 4E and 4F).
A previous study described the formation of tumors in the
larval central brain when lola was knocked down using RNAi
(Neumu¨ller et al., 2011). However, RNAi is prone to off-target ef-
fects. We have never observed tumor formation in the central
brain in two different lola null mutants (lolaE76 and lola5D2), nor af-
ter expression of a small hairpin RNA (shRNA) (Ni et al., 2011) tar-
geting lola (Figure S6A). The same study reported a neuroblastexample, the vertical bar represents the log2 ratio
log2 ration between the Dam-fusion signal and the
embryo.
6, March 31, 2014 ª2014 The Authors 689
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roblasts. As lola-N is not expressed in neuroblasts, this is likely
also to be due to off-targets.
To test whether the loss of Lola-N is critical for tumor forma-
tion, we expressed lola-N in lolaE76 mutant clones. Expression
of UAS-lola-Nwas driven by elav-GAL4 to most closely replicate
wild-type lola-N expression. lolaE76 clones expressing lola-N
never form tumors (nine of nine brains; Figure 4D). In contrast,
neither Lola-F nor Lola-H is able to inhibit tumor formation
(C. Howard, T.D.S., and A.H.B., unpublished data). Interestingly,
ectopic expression of Lola-N is also able to suppress the
prospero mutant phenotype in embryos, preventing Deadpan
expression and cell proliferation (Figure S3). Therefore, like Pros-
pero, Lola-N acts as a tumor suppressor.
Neurons Lacking lola Dedifferentiate
Lola-N is expressed in postmitotic neurons, implying that there is
active repression of stem cell genes in postmitotic neurons and
raising the possibility that lola mutant tumors arise through the
dedifferentiation of neurons. To test this hypothesis, we investi-
gated the timing of tumor formation and the cell type of origin in
lola mutants.
In prospero mutants, tumors arise from GMCs that revert to
a stem cell-like fate, expressing neuroblast genes such as
Deadpan (Choksi et al., 2006; Lee et al., 2006b). In wild-type em-
bryos, Deadpan is expressed in neuroblasts, which lie ventrally
(red cells in Figure 5A). When Prospero moves into the nucleus
of GMCs, Deadpan expression is rapidly repressed (green cells
in Figure 5A). In lola mutant embryos, Deadpan is switched off
normally in GMCs (Figure 5B) but is then ectopically expressed
in the dorsal, differentiated layer of the VNC, where neurons
are positioned (arrowheads in Figure 5B). These cells are not
GMCs or newly born neurons as they do not express Prospero
(Figure 5B). To confirm that these cells are neurons, we cos-
tained with Fasciclin II, which is expressed in neurons but not
neuroblasts (Kristiansen and Hortsch, 2010). In wild-type em-
bryos, Deadpan (neuroblasts) and Fasciclin II (neurons) are never
coexpressed (Figure 5C); however, lolamutant neurons express
both Fasciclin II and Deadpan, both in the embryo (Figure 5D)
and in the larval optic lobe (Figure 5E). We observed Deadpan
coexpressed with two further neuronal markers, Cut and Elav
(arrowheads in Figures 5F and S4). Therefore, Deadpan is prop-
erly repressed in GMCs but is then derepressed in neurons.
Next, we followed the progression over time of lolaE76 mutant
clones in the larval optic lobe (Figures 6A–6C and S5C). The
timing and position of the Deadpan-expressing cells provided
further confirmation that neurons, rather than GMCs, are the
tumor-initiating cells. Initially, we observed only neurons in lola
mutant clones in the medulla cortex (48 hr; only 1% of lola
mutant medulla cortex cells show Deadpan expression). By
72 hr, Deadpan began to be expressed in regions of the
medulla cortex where only postmitotic neurons normally reside
(5% of lola mutant cells) (Figure 6B). By 96 hr, multiple
Deadpan-positive cells were found in mutant clones (17%) in
the differentiated outer medulla cortex (Figure 6C). We observed
ectopic expression of two further neuroblast genes, Asense and
Worniu, in the medulla cortex (Figures 6D and S5A). The expres-
sion of neuroblast genes coincides with cells entering the cell cy-
cle and actively dividing (Figure 6E). We observe PH3-positive690 Developmental Cell 28, 685–696, March 31, 2014 ª2014 The Aucells in deep layers of the medulla cortex, indicating that the
lola mutant cells are actively proliferating in a region of the brain
where there is normally little or no cell division (Figure 6E,
compare lola mutant cells to surrounding wild-type neurons).
Consistent with us never observing tumors in the adult central
brain, ectopic Deadpan is not present in lola mutant clones in
the larval central brain (Figure S5B).
Knockdown of lola in neurons (elav-GAL4-driven expression of
a shRNA; Ni et al., 2011) results in dedifferentiation of neurons in
the optic lobe and the formation of tumors in the adult brain (Fig-
ures7BandFigureS6A).elav-GAL4was reported tobeexpressed
weakly in neuroblasts (Berger et al., 2007). To exclude the pos-
sibility that knockdown of lola in neuroblasts contributes to the
tumor phenotype, we drove lola shRNAi with GAL4C855a (Egger
et al., 2007). GAL4C855a is expressed in the neuroepithelium, in
optic lobe neuroblasts and inGMCs (FiguresS6C–S6E).Wenever
see tumors when lola is knocked down in these cell types. There-
fore, tumors arise only when lola is knocked down in neurons.
In addition, there is little or no expression of elav-GAL4 in neuro-
blasts in our clonal experiments (see Figure 7B). We conclude
that lolamutant neurons dedifferentiate, express stem cell genes,
and proliferate giving rise to brain tumors in the adult.
DISCUSSION
Our results reveal the temporal progression toward neuronal dif-
ferentiation. First, Prospero enters the nucleus of the newly born
GMC and initiates the repression of neural stem cell genes. Next,
Lola-N is expressed and maintains transcriptional repression in
postmitotic neurons, acting as a differentiation ‘‘lock’’ (Figures
7C and 7D). Transcription factors that act as differentiation locks
have been identified in other cell types (e.g., Pax5 in B cells;
Cobaleda et al., 2007), but not in neurons. Mutations like midlife
crisis (Carney et al., 2013), which lead to the transient derepres-
sion of neuroblast genes, are insufficient to cause neurons to
dedifferentiate and revert to a proliferating stem-cell-like state,
nor do they result in tumorigenesis.
We show that Lola-N is a potent repressor of neural stem cell
genes. Studies on vertebrate BTB-ZFs have revealed that they
act predominantly as transcriptional repressors (for review, see
Kelly and Daniel, 2006), although some, such as Miz-1, can act
as both repressors and activators (Adhikary et al., 2003). For
several BTB-ZFs, transcriptional repression is elicited through
HDACs, which deacetylate histones and promote a ‘‘closed’’
chromatin state (Kelly and Daniel, 2006). Therefore, as found
for vertebrate BTB-ZFs, Lola-N may act through HDACs to
achieve this repression.
The vertebrate proteins most similar to Lola are Zfp131, Miz-1,
and Leukemia-Related Factor (LRF). Of these, Zfp131 is ex-
pressed predominantly in the developing nervous system, the
adult brain, and the testes (Trappe et al., 2002), a similar expres-
sion pattern to that described for lola-N in flies (FlyAtlas; Chinta-
palli et al., 2007). Miz-1 is also expressed in neurons in the devel-
oping and adult mouse brain (Allen Brain Atlas; Lein et al., 2007)
and has a potent growth arrest function (Peukert et al., 1997).
Zfp131 and Miz-1 may be functionally analogous to Lola-N,
with respect to promoting ormaintaining neuronal differentiation.
That Lola-N represses cell-cycle genes in postmitotic neurons
seems surprising at first; however, there is a growing body ofthors
Figure 5. In lola Mutants, Neuroblast Genes Are Switched Off in GMCs but Reexpressed in Neurons
(A) In wild-type embryos Deadpan is switched off in GMCs and remains off.
(B) In lolaE76 embryos Deadpan is switched off normally in GMCs; however, ectopic Deadpan is observed in the dorsal more differentiated region of the VNC (see
filled arrowheads). Less organized actin structures are observed in lolaE76 embryos, compared to wild-type (see empty arrowhead), due to disruption of axonal
projections.
(C) Expression of Deadpan and FasII in wild-type stage 15 embryos. Ventral view at the level of midline neuroblasts.
(D) Deadpan and FasII expression in lola mutant embryos. Arrowheads show cells expressing both Deadpan and FasII.
(E) Coexpression of Deadpan and FasII in lola mutant clones in the developing optic lobe. Arrowheads show cells expressing both Deadpan and FasII.
(F) Coexpression of Deadpan and Cut in lola mutant clones in the developing optic lobe. Arrowheads show cells expressing both Deadpan and Cut.
Scale bars represent 20 mM. See also Figure S4.
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cell cycle in check (for review, see Herrup and Yang, 2007). Inhi-
bition of Retinoblastoma (Rb) in Purkinje neurons forces neurons
to reenter the cell cycle and replicate their DNA, but M phase is
not initiated and the neurons die (Feddersen et al., 1995). Simi-Develolarly, knockdown of Cdh1, which is required to prevent the accu-
mulation of cyclin B1 in neurons, causes neurons to enter S
phase and leads to apoptosis (Almeida et al., 2005). Therefore,
repression of cell-cycle genes is imperative as aberrant cell-cy-
cle activity in neurons can lead to neurodegeneration or cancer.pmental Cell 28, 685–696, March 31, 2014 ª2014 The Authors 691
Figure 6. Time Course of Dedifferentiation in lola Tumors
(A–C) Time course of dedifferentiation in lola tumors. In the outer medulla cortex of the developing optic lobe, ectopic Deadpan is not observed until72 hr after
clone induction (see arrowheads).
(D) Ectopic expression of the neuroblast gene Asense (see arrowheads).
(E) Ectopic division (PH3) is observed 96 hr after clone induction (see arrowheads).
Scale bars represent 20 mM. See also Figure S5.
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stem cells and their more differentiated progeny (Gupta et al.,
2009) and that some more differentiated cells, for example, in-
testinal secretory progenitors (van Es et al., 2012) and intestinal692 Developmental Cell 28, 685–696, March 31, 2014 ª2014 The Auepithelial cells (Schwitalla et al., 2013), can initiate tumors. In
lola mutants, the tumor cells of origin are postmitotic neurons
rather than GMCs (Figure 7E). In contrast to prospero mutants,
GMCs differentiate normally in lola mutants, and Deadpan isthors
Figure 7. lola Mutant Neurons Dedifferentiate to a Neural Stem Cell Fate
(A and B) Knockdown of lola in the larval optic lobe medulla cortex causes neurons to dedifferentiate and express Deadpan (arrowheads in B). MARCM clones
expressing lola shRNAi in a subset of neurons are labeled in green.
(C) Schematic diagram showing the temporal expression of Deadpan, Prospero, and Lola-N during neuronal differentiation in embryos and the developing
optic lobe.
(D) Temporal expression of Deadpan, Prospero, and Lola-N during neuronal differentiation in the larval central brain.
(E) In thewild-type nervous systemProspero turns off neural stem cell genes, such as Deadpan, in GMCs. In prosperomutants, neural stem cell genes continue to
be expressed in GMCs, leading to overproliferation and tumors. In lola mutants, Prospero represses neural stem cell genes in the GMCs. However, in neurons,
without Lola to maintain repression, neural stem cell genes are reexpressed, and the cells dedifferentiate and form tumors.
See also Figure S6.
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press Deadpan, and undergo cell division resulting in adult
brain tumors.DeveloInterestingly, the loss of lola does not cause tumor formation in
the central brain, where Prospero expression persists in neu-
rons. The diagrams in Figures 7C and 7D depict the expressionpmental Cell 28, 685–696, March 31, 2014 ª2014 The Authors 693
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type and lola mutants. In lola mutant embryos and larval optic
lobe clones, Prospero is switched off in neurons and Deadpan
is reexpressed (Figure 7C). However, in the larval central brain,
Prospero remains on in neurons (Figure 7D). We have shown
that Prospero expression can rescue the lola tumor phenotype
(Figures 4E and 4F); therefore, the persistence of Prospero in
central brain neurons may explain why Deadpan is not reex-
pressed and why tumors are not observed in the adult central
brain.
We hypothesize that Lola maintains the repression of neural
stem cell genes until they transition to a more permanent
‘‘off state.’’ BTB-zinc finger proteins are known to recruit
HDACs, and this may be the mechanism by which target
genes are more permanently locked down. In support of this
hypothesis, we find that knockdown of lola in adult flies
is no longer sufficient to cause neuronal dedifferentiation
(Figure S6B).
A long-term goal of regenerative medicine and stem cell
research is to convert cells in vivo to specific fates to allow for
the repair of damaged or diseased tissues. The ability to induce
neurons to dedifferentiate, followed by directed differentiation
to neurons of choice, would be an ideal method of repair. Mature
neurons have been shown to dedifferentiate when p53 and NF1
are knocked down simultaneously. However, this leads to
genome instability resulting in gliomas (Friedmann-Morvinski
et al., 2012). Our data suggest that a single factor can maintain
the global repression of both cell-cycle genes and neural stem
cell genes in postmitotic neurons. Factors such as Lola would
be excellent targets for realizing the goal of controlled dediffer-
entiation of neurons in vivo.
EXPERIMENTAL PROCEDURES
Fly Lines
UAS-lola-N, UAS-lola-H, UAS-lola-F, and UAS-Dam-lola-N flies were gener-
ated by PCR amplifying the full coding sequences from an embryonic
cDNA library and cloning it into pUASTattB (Bischof et al., 2007) and
pUAST-NDam (Choksi et al., 2006), respectively (for primer sequences, see
Supplemental Experimental Procedures). Transgenic flies were generated
as previously described (Choksi et al., 2006). UAS-lola-shRNAi (based
on the approach described by Ni et al., 2011) was generated using the
method available on the TRiP website (http://www.flyrnai.org/supplement/
2ndGenProtocol.pdf) using the passenger strand sequence CACGACA
GATCTCAGGATGAA and the pWALIUM20 vector. MARCM clones were
generated using the following driver lines: elav-GAL4, UAS-mCD8-GFP,
hsFLP; FRT42D, tub-Gal80/CyO and tub-GAL4, UAS-nuGFP, hsFLP;
FRT42D, tub-Gal80/CyO, and the following FRT lines: lolaE76, FRT42D/CyO,
lola5D2, FRT42D/CyO, lolaE76, FRT42D/CyO; UAS-lola-N/TMBb, and
FRT42D; UAS-lola-shRNAi. lolaE76 is a protein null mutation, removing all iso-
forms of lola (Goeke et al., 2003). lola5D2 (P-element insertion at the transcrip-
tional start site) is a strong hypomorph for lola (Giniger et al., 1994). w1118
were used as wild-type flies for immunohistochemistry experiments.
Yeast One-Hybrid
The yeast one-hybrid assay was performed using the Matchmaker Yeast
One-Hybrid kit (Clontech) and protocol. To make the DNA bait construct,
we first modified the Clontech bait vector pHis2.1 to make it compatible
with our cDNA library by replacing the Trp selection gene with the Leu selec-
tion gene to give pHis2.2. An oligo with six copies of the bait site interspersed
with random 5-mer (Supplemental Experimental Procedures) was annealed to
its reverse complement and cloned into pHis2.2 using MluI and SpeI. This
was transformed into Y187 yeast. One hundred micrograms of a 4–17 hr694 Developmental Cell 28, 685–696, March 31, 2014 ª2014 The Auembryonic cDNA library (with cDNAs fused to an activator domain)
was transformed into yeast carrying the bait construct and plated onto
His/Leu/Trp selective media containing 50 mM 3-AT. Positive colonies
were picked, suspended in 0.2% SDS, heated at 95C for 5 min, and centri-
fuged, and the supernatant was purified using a QIAGEN PCR purification kit.
For sequencing, the cDNA inserts were PCR amplified (for primer sequences,
see Supplemental Experimental Procedures) and sequenced using the
forward primer.
Immunohistochemistry
Larval and adult CNS were dissected in PBS and then fixed for 15–20 min in
PBS containing 4% formaldehyde (ultra pure), 0.5 mM EGTA, and 5 mM
MgCl2. Wash solution was PBS with 0.3% Triton X-100. The anti-Lola-N
antibody was generated by synthesis of the peptides GVELDSIDDTMTEV
and GSPLSWTYDAVKIC (corresponding to the unique C-terminal region)
and injection into rabbits (Moravian Biotechnology). Serum was purified
using the GVELDSIDDTMTEV peptide and used at a concentration of
1:10. Other primary antibodies used were chicken anti-GFP (1 in 2,000)
(ab13970, Abcam), mouse anti-Discs Large (c) (1 in 70) (4F3, Developmental
Studies Hybridoma Bank [DSHB]), rat anti-Elav (c) (1 in 70) (7E8A10, DSHB),
mouse anti-Fas II (c) (1 in 20) (1D4, DSHB), guinea pig anti-Deadpan
(1 in 500) (J.B. Skeath), mouse anti-Repo (c) (1 in 70) (8D12, DSHB), rabbit
anti-PH3 (1 in 100) (06-570, Upstate), rat anti-PH3 (1 in 150) (ab10543,
Abcam), mouse anti-Prospero (c) (1 in 70) (MR1A, DSHB), mouse anti-Cut
(c) (1 in 30) (2B10, DSHB), rat anti-Worniu (0.8 in 1) (C.Q. Doe), rabbit
anti-Asense (1 in 1000) (Y. N. Jan). Appropriate combinations of Alexa-
coupled secondary antibodies (Invitrogen) were subsequently applied.
Phalloidin-546 (Invitrogen) was used for actin staining (1 in 100). Samples
were analyzed with a Leica SP2, Leica SP5, or Zeiss LSM510 confocal
microscope. Adobe Photoshop and Illustrator were used to generate
figures.
DamID
Preparation of Dam-methylated DNA from stage 10–11 embryos was per-
formed as previously described (Choksi et al., 2006). The Dam-only and
Dam-Lola-N samples were labeled and hybridized together on a whole
genome 2.1 million feature tiling array, with 50- to 75-mer oligonucleotides
spaced at approximately 55 bp intervals (Nimblegen systems). Arrays were
scanned and intensities extracted (Nimblegen Systems). Three biological rep-
licates (with one dye-swap) were performed. Log2 ratios of each oligo were
median normalized.
DamID Analysis
A peak finding algorithm with FDR analysis was used to identify significant
binding sites (Wolfram et al., 2012) (PERL script available on request). All peaks
spanning four or more consecutive probes (greater than900 bp for low-den-
sity arrays and greater than400 bp for high-density arrays) over a 2-fold ratio
change were assigned a FDR value.
Motif Analysis
A perl program was used to identify peak structures within the DamID data
(script available on request), and the top 1,000 peaks (based on peak height)
were analyzed using the MICRA program (Southall and Brand, 2009). Lola-N
data were first converted to release four coordinates before running MICRA.
To generate a PWM from enriched 8-mer, the top 50 enriched 8-mer were
analyzed by MEME-ChIP (Machanick and Bailey, 2011), with their abundance
represented in the input fasta file.
In Situ Hybridizations
In situ hybridization was performed as previously described (Choksi et al.,
2006). For primer sequences used to generate in situ probes, see the Supple-
mental Experimental Procedures.
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